Barr Laboratories
Teva agrees $225 million fee in antitrust case
January 27, 2017Medical Communications Barr Laboratories, Teva, fine
Barr Laboratories, a subsidiary of Teva Pharmaceuticals, has settled an antitrust class action for $225 million. The case relates to …
Latest content
Medtronic secures CE Mark for new cardiac pacing portfolio
October 30, 2026
Dermatology leader Doncker is new Onicor CEO
October 29, 2026
October 28, 2026
